H Lundbeck A/S (HLUN-B.CO) Diversifiers

Equity · Currency in DKK · Last updated Jun 5, 2026

H. Lundbeck A/S, a Danish biopharmaceutical company founded in 1915, specializes in developing and selling pharmaceuticals for psychiatric and neurological disorders globally, with key products for conditions like schizophrenia, depression, Parkinson's disease, and Alzheimer's, and collaborates with entities like Otsuka Pharmaceuticals and Alloy Therapeutics.

Looking to balance out your exposure to HLUN-B.CO? The ETFs below have the lowest correlation with HLUN-B.CO — they tend to move on their own, which can help reduce risk when HLUN-B.CO drops. The stock ideas table highlights individual companies that behave independently from HLUN-B.CO.

No Diversifiers Found for HLUN-B.CO

We do not have enough correlation history to rank diversifiers for this symbol yet.

Diversification Analysis

Build a portfolio that complements HLUN-B.CO

Add HLUN-B.CO to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with HLUN-B.CO